About Jakob Uszkoreit
Form D filings for Inceptive Nucleics in 2023 list Jakob Uszkoreit as chief executive officer and director.
Jakob Uszkoreit first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jakob Uszkoreit in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jakob Uszkoreit works with at each company, as listed on that company's latest Form D.
Inceptive Nucleics, Inc. · Form D, Sep 20, 2023
KH
Kevin Heyries
Executive officer
VP
Vijay Pande
Director
DA
Diana Ajuria
Executive officer
DK
Do Soon Kim
Executive officer